Skip to content

A trial to determine the feasibility of embedding an ePrescribing-based Antimicrobial Stewardship (ePAMS+) intervention into existing ePrescribing systems within a hospital setting

Complex ePrescribing-based Antimicrobial Stewardship intervention for Hospitals (ePAMS+) Feasibility Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13429325
Enrollment
1958
Registered
2022-03-24
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Management of antibiotic use within hospital settings. Not Applicable

Interventions

Current interventions as of 02/11/2022: The ePAMS+ Feasibility trial to assess the feasibility of embedding the ePAMS+ intervention and extracting trial outcome measures using administrative data with

Sponsors

University of Edinburgh
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Medical records: 1. Adults >=16 years admitted to hospital as in-patients 2. Patients being treated with antibiotics (identified as Antibiotic Order Plans initiated and/or existing antibiotic use flagged within the electronic prescribing system)

Exclusion criteria

Exclusion criteria: Medical records: 1. Children <16 years

Design outcomes

Primary

MeasureTime frame
1. Total antibiotic consumption measured as the number of defined daily doses (DDD), assessed overall and at site/ward level 2. Completeness of data extracted and whether standardised queries to capture data from Cerner systems are feasible/assessed via monthly data extracts 3. Assessment of the feasibility of measuring defined outcomes using extracted data

Secondary

MeasureTime frame
Mapping of critical decision points within Cerner systems to core principles of the intervention to develop fidelity index items, and determine how standardised queries to capture data from Cerner will enable coding of item response options (e.g. 'present', 'absent but should be present', 'not applicable') for automation of this coding structure for the cluster-randomised trial The following outcomes will be assessed for feasibility (added 16/05/2022): Length of hospital stay Days of therapy (and intravenous therapy) Diagnostics Number of antibiotics prescribed Number of antibiotic courses Repeat courses for same indication Number of courses for same indication Switches - of frequency - of dose - from intravenous to oral - from oral to intravenous - to alternative antimicrobial - from narrow to broad spectrum Discontinuation of therapy Number of courses concordant with local guidelines for antibiotic choice/duration Resistance rates Susceptibility Acquisition of multi-drug resistant organism Healthcare-associated infection Episodes of - Clostridium difficile infection (CDI) - methicillin- resistant Staphylococcus aureus (MRSA) - gram-negative bacilli (GNB) Added 01/11/2022: Site staff ePAMS+ training information will be captured on the Learning Management System to assess completion of training (i.e. professional discipline, date/time of module completion, time spent on learning and pre and post-test scores)

Countries

England, United Kingdom

Contacts

Public ContactChristopher J Weir
ePAMS.trials@ed.ac.uk+44 131 651 9928

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 5, 2026